Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Masahito Ohida is active.

Publication


Featured researches published by Masahito Ohida.


Gastrointestinal Endoscopy | 1999

Usefulness of endoscopic aspiration mucosectomy as compared with strip biopsy for the treatment of gastric mucosal cancer

Satoshi Tanabe; Wasaburo Koizumi; Mikio Kokutou; Hiroshi Imaizumi; Keita Ishii; Mitsuhiro Kida; Yasushi Yokoyama; Masahito Ohida; Katsunori Saigenji; Hitoshi Shimao; Hiroyuki Mitomi

BACKGROUND Several techniques are available for the endoscopic treatment of gastric intramucosal cancers, but their advantages and disadvantages have not been adequately evaluated. We compared the therapeutic usefulness of endoscopic aspiration mucosectomy with that of strip biopsy. METHODS Between May 1995 and May 1997, we performed strip biopsy (May 1995 through February 1996) or endoscopic aspiration mucosectomy (March 1996 through May 1997) in a consecutive series of patients with intestinal-type intramucosal cancer. Parameters of assessment included the following: size of removed specimens, en bloc resection rate, time required for resection, duration of hospitalization, and complications. RESULTS Forty-nine patients with gastric intramucosal cancers underwent endoscopic aspiration mucosectomy and 44 underwent strip biopsy. The two groups were similar with respect to age, gender, and lesion macroscopic appearance, size, and site. The mean longest diameter of the resected specimens was significantly greater with endoscopic aspiration mucosectomy (20.3 +/- 3.4 mm) than with strip biopsy (15. 8 +/- 4.4 mm) (p < 0.001). The rate of en bloc resection (resection of an entire lesion in one procedure) was significantly higher with endoscopic aspiration mucosectomy (61.2%, 30 of 49) than with strip biopsy (36.4%, 16 of 44) (p < 0.05). The number of specimens obtained by piecemeal resection was slightly, but not significantly, higher with strip biopsy (2.4 +/- 1.7) than with endoscopic aspiration mucosectomy (2.0 +/- 1.7). The time required for treatment was similar for each procedure. The duration of hospitalization was significantly shorter with endoscopic aspiration mucosectomy (12.8 +/- 5.3 days) than with strip biopsy (15.9 +/- 74 days) (p < 0.05). As for complications, the rate of bleeding was 20. 5% (9 of 44) with strip biopsy and 10.2% (5 of 49) with endoscopic aspiration mucosectomy; bleeding was controlled in all cases by treatment with a heater probe. CONCLUSIONS Endoscopic resection of large gastric intramucosal tumors is easier with endoscopic aspiration mucosectomy compared with strip biopsy. Endoscopic aspiration mucosectomy is a useful procedure for en bloc resection.


Gastrointestinal Endoscopy | 1986

A new disk method for the endoscopic determination of gastric ulcer area

Haruya Okabe; Masahito Ohida; Nobuyuki Okada; Toshiharu Mitsuhashi; Tomoe Katsumata; Katsunori Saigengi; Kenichi Nakahashi

The authors devised a new method using measure plates for the endoscopic measurement of gastric ulcer area. A grid composed of 2.5-mm squares was photographed by the endoscope with lens-object-distance (LOD) being changed every 2.5 mm precisely, and the obtained images of the square pattern were printed on glass plates, which were used as measure plates. The ulcer size was determined by mounting an endoscopic photograph of the ulcer on the corresponding glass plate with the same LOD, projecting them on the screen by a projector and counting the number of squares within the ulcer area. In this way the gastric ulcer size could be determined with an average aberration ratio of 5.6% or less, irrespective of LOD.


Journal of Gastroenterology and Hepatology | 1998

A prospective randomized study of amoxycillin and omeprazole with and without metronidazole in the eradication treatment of Helicobacter pylori

Wasaburo Koizumi; Satoshi Tanabe; Kenichi Hibi; Hiroshi Imaizumi; Masahito Ohida; Haruya Okabe; Katsunori Saigenji; Isao Okayasu

A combination of amoxycillin and omeprazole is often used to treat Helicobacter pylori infection. A three‐drug regimen comprising metronidazole, amoxycillin and omeprazole has been proposed as an alternative therapy. In a prospective, randomized, comparative study, we evaluated these two regimens with respect to safety and efficacy in patients with H. pylori infection. Sixty patients with peptic ulcer (gastric, 32 patients; duodenal, 28 patients) who had a history of ulcer recurrence were randomly assigned to dual therapy with amoxycillin (500 mg three times daily for 2 weeks) and omeprazole (20 mg once daily for 8 weeks) or to triple therapy with metronidazole (500 mg twice daily for 2 weeks) plus amoxycillin and omeprazole, given in the same dosages as dual therapy. Forty‐eight patients completed the protocol; treatment was discontinued because of side effects in nine patients, and three patients dropped out of the study. On the basis of all patients treated, the rate of H. pylori eradication was significantly higher for triple therapy 20/23 cases, 87.0%; 95% confidence interval (CI), 0.664–0.972) than for dual therapy 13/25, 52.0%; 0.313–0.722; P < 0.05). On an intention‐to‐treat basis, the difference between the groups in the rate of H. pylori eradication was marginally significant (P= 0.06 [0.028–0.512]). Side effects were reported by five patients receiving triple therapy (skin rash, one; nausea, two; headache, one; abdominal pain, one), and four patients receiving dual therapy (skin rash, two; abdominal pain, one; diarrhoea, one). All side effects resolved spontaneously after termination of treatment. There was no significant difference in safety between the two regimens. Triple therapy with metronidazole, amoxycillin, and omeprazole was significantly more effective for the eradication of H. pylori than dual therapy with amoxycillin and omeprazole alone. The safety of these regimens was similar, and triple therapy was found to be clinically acceptable.


Digestive Endoscopy | 1992

Factors Influencing the Relapse of Gastric Ulcers During H2-Receptor Antagonist Maintenance Therapy

Katsunori Saigenji; Yoshiteru Azuumi; Yasusi Yokoyama; Takeshi Ashihara; Wasaburo Koizumi; Toshiharu Mitsuhashi; Masahito Ohida

Abstract: We performed H2‐receptor antagonist maintenance therapy for 2 years on 146 patients with healed gastric ulcers (including those with concurrent duodenal ulcers), and determined the cumulative endoscopic and symptomatic recurrence rates. We also investigated the factors involved in ulcer recurrence in the first 12 months of maintenance therapy. The cumulative endoscopic non‐recurrence rate was 70.0% at 12 months and 57.2% at 24 months, while the cumulative symptomatic non‐recurrence rate was 84.8% at 12 months and 75.0% at 24 months. The factors contributing to endoscopic recurrence were the presence of a concomitant disease, the presence of duodenal ulcer, the type of ulcer, and the endoscopic stage at healing. The factors related to symptomatic recurrence were smoking and the type of ulcer. Multivariate analysis showed that the type of ulcer, smoking, and the endoscopic stage at healing influenced the risk of recurrence.


Digestive Endoscopy | 1992

Correlation between α1–Adrenoceptors in Biopsy Specimens and Endoscopic Color Changes of Human Gastric Ulcer

Masahito Ohida; Hiromi Hayashi; Shin Kikuchi; Hiroshi Imaizumi; Satoshi Tanabe; Wasaburo Koizumi; Yasushi Yokoyama; Katsunori Saigenji

α1–Adrenoceptors were measured in the scar tissue (U) and marginal normal mucosa (C) of human gastric ulcers by radio‐binding assay using [3H]‐prazosin as the ligand. The specific radioactivity binding was calculated for the membrane‐rich fractions of the U and C regions along with U/C ratio, and the relationship between the scar color tone and α–adrenoceptor binding levels was studied by conventional endoscopy and pharmacoendoscopy


Gastrointestinal Endoscopy | 2001

Rendu-Osler-Weber disease successfully treated by argon plasma coagulation

Tadashi Kitamura; Satoshi Tanabe; Wasaburou Koizumi; Masahito Ohida; Katsunori Saigengi; Hiroyuki Mitomi


Hepato-gastroenterology | 2003

Effect of anti-helicobacter pylori IgG antibody titer following eradication of helicobacter pylori infection

Wasaburo Koizumi; Satoshi Tanabe; Hiroshi Imaizumi; Kenichi Hibi; Mitsuhiro Kida; Masahito Ohida; Isao Okayasu; Katsunori Saigenji


Hepato-gastroenterology | 2003

Inhibition of peptic ulcer relapse by ranitidine and ecabet independently of eradication of Helicobacter pylori: a prospective, controlled study versus ranitidine.

Wasaburo Koizumi; Satoshi Tanabe; Hiroshi Imaizumi; Mitsuhiro Kida; Masahito Ohida; Yoko Koshida; Hiroyuki Mitomi; Yoshio Hosaka; Shizuka Nagaba; Tohru Sasaki; Katsuhiko Higuchi; Katsunori Saigenji


Progress of Digestive Endoscopy(1972) | 1995

Endoscopic Hemostasis Using Clip for a Bleeding Duodenal Diverticulum

Hiroshi Imaizumi; Youko Inamura; Masahito Ohida; Satoshi Sugano; Satoshi Tanabe; Wasaburou Koizumi; Katsunori Saigenji; Yasushi Yokoyama


Acta Gastro-Enterologica Belgica | 1994

A STUDY ON DUODENAL ULCERS BY ULTRASONIC PROBE: APPLICATION OF JELLY INFUSION METHOD

Yukihito Yamada; Tetsuaki Sakaguchi; Mitsuhiro Kida; Makoto Noto; Keita Ishii; Satoshi Tanabe; Wasaburou Koizumi; Yasushi Yokoyama; Toshiharu Mitsuhashi; Masahito Ohida; Katsunori Saigenji

Collaboration


Dive into the Masahito Ohida's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hiroyuki Mitomi

Dokkyo Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge